ATP13A3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.410010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.400380E-01
Normal-vs-Stage2
1.921780E-02
Normal-vs-Stage3
9.584000E-02
Normal-vs-Stage4
3.804000E-01
Stage1-vs-Stage2
7.571400E-01
Stage1-vs-Stage3
1.660990E-01
Stage1-vs-Stage4
7.913400E-01
Stage2-vs-Stage3
2.853600E-01
Stage2-vs-Stage4
5.624600E-01
Stage3-vs-Stage4
3.087400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.790000E-01
Normal-vs-AfricanAmerican
6.692200E-01
Normal-vs-Asian
4.036300E-02
Caucasian-vs-AfricanAmerican
4.375400E-01
Caucasian-vs-Asian
6.148800E-01
AfricanAmerican-vs-Asian
3.832000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.464200E-02
Normal-vs-Female
3.059000E-01
Male-vs-Female
4.683400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.720000E-01
Normal-vs-Age(41-60Yrs)
1.032050E-01
Normal-vs-Age(61-80Yrs)
4.835200E-03
Normal-vs-Age(81-100Yrs)
2.646500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.249780E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.013000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.019200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.722900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.149420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.479000E-01
Normal-vs-Daily Drinker
2.081200E-01
Normal-vs-Weekly Drinker
2.691000E-01
Normal-vs-Occasional Drinker
7.398400E-02
Normal-vs-Social Drinker
1.044250E-01
Non Drinker-vs-Daily Drinker
3.027000E-01
Non Drinker-vs-Weekly Drinker
7.043400E-01
Non Drinker-vs-Occasional Drinker
2.267600E-01
Non Drinker-vs-Social Drinker
2.991600E-01
Daily Drinker-vs-Weekly Drinker
2.047200E-01
Daily Drinker-vs-Occasional Drinker
5.732400E-02
Daily Drinker-vs-Social Drinker
9.444200E-02
Weekly Drinker-vs-Occasional Drinker
4.695600E-01
Weekly Drinker-vs-Social Drinker
5.462400E-01
Occasional Drinker-vs-Social Drinker
9.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.602200E-01
Normal-vs-Grade 2
4.623500E-02
Normal-vs-Grade 3
8.855700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.440800E-01
Grade 1-vs-Grade 3
1.884360E-01
Grade 1-vs-Grade 4
3.602200E-01
Grade 2-vs-Grade 3
9.887900E-02
Grade 2-vs-Grade 4
4.623500E-02
Grade 3-vs-Grade 4
8.855700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.263850E-02
Normal-vs-NonDiabetic
2.701600E-01
Diabetic-vs-NonDiabetic
4.386800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.070800E-01
Normal-vs-NoPancreatitis
2.725000E-01
Pancreatitis-vs-NoPancreatitis
1.674610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.375680E-02
Normal-vs-N1
1.958430E-02
N0-vs-N1
3.191400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.536300E-02
Normal-vs-TP53-NonMutant
9.224300E-03
TP53-Mutant-vs-TP53-NonMutant
1.002850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
